50
Participants
Start Date
July 15, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
treatment option-sintilimab plus fruquintinib
sintilimab plus fruquintinib
treatment option-fruquintinib alone
fruquintinib alone
RECRUITING
The First Hospital of Jilin University, Changchun
The First Hospital of Jilin University
OTHER